Clinical Trials

NCT Number: NCT04258813 Phase: NA Trial Summary: The proposed ONE TEAM Study is an 18-month, cluster randomized controlled trial. This study will use a sequential multiple assignment randomized trial (SMART) design with a second – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Duke University Acronym: ONE TEAM

NCT Number: NCT04038502 Phase: Phase 2 Trial Summary: This is an unblinded, randomized clinical study comparing the efficacy of DNA damaging chemotherapy using carboplatin, to standard of care therapy for patients who have metastatic – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): VA Office of Research and Development Acronym: COBRA

NCT Number: NCT04104776 Phase: Phase 1|Phase 2 Trial Summary: First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Constellation Pharmaceuticals Acronym:

NCT Number: NCT04109729 Phase: Phase 1|Phase 2 Trial Summary: This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a ph – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Utah Acronym: Rad2Nivo

NCT Number: NCT03987386 Phase: Phase 3 Trial Summary: This phase III trial studies how well hypofractionated radiation therapy works compared to the conventional one in treating patients with prostate cancer. Radiation therapy uses hi – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI) Acronym:

NCT Number: NCT03976843 Phase: Phase 2 Trial Summary: People with prostate cancer usually have their cancer imaged with a CT scan and bone scan. They then have their prostate gland removed. Researchers want to test a scan that might p – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI)|National Institutes […]

NCT Number: NCT03987217 Phase: Early Phase 1 Trial Summary: This trial studies how well resistance training with or without creatine monohydrate supplement works in improving body composition and health outcomes in patients with prostate ca – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Utah|National Cancer Institute (NCI) Acronym:

NCT Number: NCT03866382 Phase: Phase 2 Trial Summary: This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that that has spread f – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): National Cancer Institute (NCI) Acronym:

NCT Number: NCT03880422 Phase: Not Applicable Trial Summary: This trial studies how well nutrition and exercise interventions work in reducing androgen deprivation therapy-induced obese frailty in prostate cancer survivors. Individualized nu – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Roswell Park Cancer Institute Acronym:

NCT Number: NCT03772834 Phase: Phase 2|Phase 3 Trial Summary: This phase II/III trial studies how well methylphenidate and exercise work in reducing cancer-related fatigue in patients with prostate cancer. Methylphenidate is a type of central – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): M.D. Anderson Cancer Center|National Cancer Institute (NCI) Acronym: